Ryoko Okamoto Selected Research

Ryoko Okamoto Research Topics

Disease

10	Neoplasms (Cancer) 01/2023 - 11/2008
3	Breast Neoplasms (Breast Cancer) 01/2023 - 01/2019
2	Neoplasm Metastasis (Metastasis) 01/2021 - 01/2019
1	Glioblastoma (Glioblastoma Multiforme) 06/2020
1	Splenomegaly 02/2015
1	Thyroid Neoplasms (Thyroid Cancer) 01/2014
1	Carcinogenesis 01/2014
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2014
1	Atherosclerosis 01/2014
1	Hypercalcemia (Milk Alkali Syndrome) 01/2014
1	Infections 01/2014
1	Prostatic Neoplasms (Prostate Cancer) 05/2012
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 09/2010
1	Pancreatic Neoplasms (Pancreatic Cancer) 07/2009
1	Drug-Related Side Effects and Adverse Reactions 07/2009
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2008
1	Carcinoma (Carcinomatosis) 03/2005

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2014 - 01/2014
2	Messenger RNA (mRNA)IBA 01/2014 - 01/2014
2	1,25-dihydroxyvitamin DIBA 05/2012 - 11/2008
1	AlpelisibIBA 01/2023
1	Acetylcysteine (Siran)FDA LinkGeneric 01/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Differentiation AntigensIBA 01/2022
1	Estrogen ReceptorsIBA 01/2022
1	InterferonsIBA 01/2021
1	B7-H1 AntigenIBA 06/2020
1	NOC 18IBA 06/2020
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 06/2020
1	GlucocorticoidsIBA 01/2019
1	Hormones (Hormone)IBA 01/2019
1	Phosphotransferases (Kinase)IBA 01/2019
1	Glucocorticoid Receptors (Glucocorticoid Receptor)IBA 01/2019
1	CytokinesIBA 02/2015
1	Bevacizumab (Avastin)FDA Link 02/2015
1	Interleukin-6 (Interleukin 6)IBA 02/2015
1	Laminin (Merosin)IBA 01/2014
1	LigandsIBA 01/2014
1	LDL Lipoproteins (beta Lipoproteins)IBA 01/2014
1	Small Interfering RNA (siRNA)IBA 01/2014
1	CrizotinibIBA 01/2014
1	ARQ 197IBA 01/2014
1	CholesterolIBA 01/2014
1	LDL Receptors (LDL Receptor)IBA 01/2014
1	Fatty Acid-Binding ProteinsIBA 01/2014
1	Calcitriol (Calcijex)FDA LinkGeneric 01/2014
1	Proto-Oncogene Proteins c-etsIBA 05/2012
1	inecalcitolIBA 05/2012
1	AndrogensIBA 05/2012
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 05/2012
1	Prostate-Specific Antigen (Semenogelase)IBA 05/2012
1	hydroxide ionIBA 05/2012
1	OligonucleotidesIBA 09/2010
1	Dihydrotachysterol (AT 10)IBA 07/2009
1	cucurbitacin BIBA 07/2009
1	Caspase 3 (Caspase-3)IBA 07/2009
1	Caspase 9IBA 07/2009
1	Gemcitabine FDA Link 07/2009
1	TriterpenesIBA 07/2009
1	Cholecalciferol (Vitamin D3)FDA Link 11/2008
1	Vitamin D FDA LinkGeneric 01/2008
1	poliovirus receptorIBA 03/2005

Therapy/Procedure

4	Therapeutics 01/2021 - 09/2010
2	Immunotherapy 01/2021 - 06/2020
2	Drug Therapy (Chemotherapy) 05/2012 - 07/2009
1	Induction Chemotherapy 01/2014